David Larsen Analyst PerformanceManaging Director at BTIG ResearchDavid Larsen is a stock analyst at BTIG Research focused in the healthcare sector, covering 30 publicly traded companies. Over the past year, David Larsen has issued 65 stock ratings, including buy and hold recommendations. While full access to David Larsen's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Larsen's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings144 Last 10 YearsBuy Recommendations75.18% 106 Buy RatingsCompanies Covered30 Unique Companies Ratings Distribution141RatingsDistribution of strong buy, buy, hold, and sell ratings by David Larsen.RatingPercentageCount Strong Buy0.0%0 ratings Buy75.2%106 ratings Hold24.8%35 ratings Sell0.0%0 ratingsOut of 141 total stock ratings issued by David Larsen at BTIG Research, the majority (75.2%) have been Buy recommendations, followed by 24.8% Hold.Best & Worst CallsBest Call0000.0%CYRXJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%OMCLDec 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ63.3% of companies on NASDAQ19 companiesNYSE33.3% of companies on NYSE10 companiesOTCMKTS3.3% of companies on OTCMKTS1 companyDavid Larsen, an analyst at BTIG Research, currently covers 30 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare28 companies93.3%Technology1 company3.3%Miscellaneous1 company3.3%David Larsen of BTIG Research specializes in stock coverage within the Healthcare sector, with additional focus on Technology and companies.Coverage IndustriesIndustryPercentageHEALTHCARE PROVIDERS & SERVICES19 companies63.3%HEALTHCARE TECHNOLOGY5 companies16.7%HEALTHCARE EQUIPMENT & SUPPLIES2 companies6.7%LIFE SCIENCES TOOLS & SERVICES2 companies6.7%SOFTWARE1 company3.3%Miscellaneous1 company3.3% About David LarsenDavid Larsen, Managing Director, is a BTIG Healthcare IT and Digital Health Analyst. Prior to BTIG, Mr. Larsen was the Founder and Senior Analyst in Healthcare IT and Digital Health at Verity Research. Previously as Managing Director, he was a Senior Analyst in Healthcare IT and Distribution Research at SVB Leerink, where he spent more than a decade. Earlier in his career, Mr. Larsen was an Associate Analyst within Healthcare Services at Cowen and Company and SunTrust Robinson Humphrey. He was also a Senior Consultant within the Healthcare Practice at PricewaterhouseCoopers and a Senior Financial Analyst at Care-Group Health System. Institutional Investor recognized Mr. Larsen as a Rising Star in 2011, 2012 and 2013 for healthcare technology and distribution coverage. In 2015, he was recognized by the Starmine Awards as the #1 earnings predictor for healthcare providers and services. Mr. Larsen earned an MBA in healthcare management and entrepreneurship from Boston University and a BA in economics from Boston College. He is also a member of the CFA Society of Boston.Follow on LinkedIn David Larsen's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsHSICHenry Schein8/5/2026Reiterated Rating$89.11$100.00Buy$0.0000.00% ROIBTSGBrightSpring Health Services8/3/2026Reiterated Rating$59.71$90.00Buy$0.0000.00% ROIMDLNMedline7/31/2026Reiterated Rating$39.12$55.00Buy$0.0000.00% ROICYRXCryoPort7/24/2026Boost Price Target$16.03$25.00Buy$0.0000.00% ROICCSIConsensus Cloud Solutions7/24/2026Boost Price Target$34.55$45.00Buy$0.0000.00% ROIHQYHealthEquity7/24/2026Boost Price Target$94.33$115.00Buy$0.0000.00% ROIPGNYProgyny7/24/2026Boost Price Target$30.70$40.00Buy$0.0000.00% ROILFSTLifeStance Health Group7/24/2026Boost Price Target$10.81$15.00Buy$0.0000.00% ROIOMDAOmada Health7/17/2026Initiated Coverage$23.67$30.00Buy$0.0000.00% ROIOMDAOmada Health7/17/2026Initiated Coverage$23.70$30.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. TOIOncology Institute7/9/2026Boost Price Target$5.85$9.00Buy$0.0000.00% ROIBTSGBrightSpring Health Services6/22/2026Boost Price Target$66.25$90.00Buy$0.0000.00% ROIHSICHenry Schein6/11/2026Upgrade$78.85$100.00Buy$0.0000.00% ROITOIOncology Institute6/8/2026Boost Price Target$4.87$8.00Buy$0.0000.00% ROIVEEVVeeva Systems6/4/2026Reiterated Rating$178.69$340.00Buy$0.0000.00% ROIASTHAstrana Health6/2/2026Reiterated Rating$37.76$50.00Buy$0.0000.00% ROIDOCSDoximity5/14/2026Downgrade$23.52Neutral$0.0000.00% ROIHIMSHims & Hers Health5/12/2026Reiterated Rating$29.12Neutral$0.0000.00% ROILFSTLifeStance Health Group5/8/2026Boost Price Target$8.85$12.00Buy$0.0000.00% ROIASTHAstrana Health5/8/2026Boost Price Target$36.08$50.00Buy$0.0000.00% ROIMDLNMedline5/7/2026Reiterated Rating$42.01$55.00Buy$0.0000.00% ROICYRXCryoPort5/5/2026Boost Price Target$10.21$17.00Buy$0.0000.00% ROILFMDLifeMD5/4/2026Reiterated Rating$5.00$10.00Buy$0.0000.00% ROIBTSGBrightSpring Health Services5/4/2026Boost Price Target$52.58$65.00Buy$0.0000.00% ROIHSICHenry Schein4/16/2026Initiated Coverage$77.42Neutral$0.0000.00% ROIBTSGBrightSpring Health Services3/19/2026Reiterated Rating$43.07$55.00Buy$0.0000.00% ROILFMDLifeMD3/10/2026Reiterated Rating$3.12$10.00Buy$0.0000.00% ROITOIOncology Institute3/9/2026Reiterated Rating$2.78$7.00Buy$0.0000.00% ROIMDLNMedline3/9/2026Reiterated Rating$43.83$55.00Buy$0.0000.00% ROIPGNYProgyny3/5/2026Lower Price Target$17.62$30.00Buy$0.0000.00% ROIBTSGBrightSpring Health Services3/2/2026Reiterated Rating$41.43$55.00Buy$0.0000.00% ROIEVHEvolent Health2/25/2026Lower Price Target$2.56$8.00Buy$0.0000.00% ROIHIMSHims & Hers Health2/24/2026Downgrade$15.47Neutral$0.0000.00% ROIHQYHealthEquity2/17/2026Lower Price Target$73.88$110.00Buy$0.0000.00% ROICCSIConsensus Cloud Solutions2/17/2026Boost Price Target$29.61$40.00Buy$0.0000.00% ROIDOCSDoximity2/6/2026Lower Price Target$33.30$50.00Buy$0.0000.00% ROIEVHEvolent Health2/2/2026Lower Price Target$3.21$10.00Buy$0.0000.00% ROIBTSGBrightSpring Health Services2/2/2026Boost Price Target$39.27$55.00Buy$0.0000.00% ROILFSTLifeStance Health Group2/2/2026Boost Price Target$7.07$11.00Buy$0.0000.00% ROIHIMSHims & Hers Health2/2/2026Lower Price Target$27.15$60.00Buy$0.0000.00% ROIPorter flew 3,300 miles to investigate this system (Ad)Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.Watch the full investigation and decide for yourselfASTHAstrana Health2/2/2026Lower Price Target$22.74$40.00Buy$0.0000.00% ROIMDLNMedline1/21/2026Reiterated Rating$44.15$55.00Buy$0.0000.00% ROIMDLNMedline1/21/2026Set Price Target$43.23$55.00$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$50.00Buy$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$42.72$50.00Buy$0.0000.00% ROIBTSGBrightSpring Health Services12/23/2025Boost Price Target$38.00$50.00Buy$0.0000.00% ROISLPSimulations Plus12/18/2025Downgrade$18.70Neutral$0.0000.00% ROILFSTLifeStance Health Group12/12/2025Boost Price Target$6.76$10.00Buy$0.0000.00% ROIPIIIP3 Health Partners12/12/2025Reiterated Rating$5.11Neutral$0.0000.00% ROIAGLAgilon Health12/12/2025Reiterated Rating$0.72Neutral$0.0000.00% ROIHQYHealthEquity12/4/2025Reiterated Rating$98.64$130.00Buy$0.0000.00% ROIVEEVVeeva Systems11/21/2025Reiterated Rating$271.01$340.00Buy$0.0000.00% ROILFMDLifeMD11/18/2025Lower Price Target$4.73$10.00Buy$0.0000.00% ROIEVHEvolent Health11/7/2025Lower Price Target$5.16$16.00Buy$0.0000.00% ROIASTHAstrana Health11/7/2025Lower Price Target$26.76$45.00Buy$0.0000.00% ROILFSTLifeStance Health Group11/6/2025Boost Price Target$6.25$9.00Buy$0.0000.00% ROIHIMSHims & Hers Health11/4/2025Reiterated Rating$44.34$85.00Buy$0.0000.00% ROIBTSGBrightSpring Health Services10/29/2025Boost Price Target$34.00$41.00Buy$0.0000.00% ROITOIOncology Institute10/21/2025Reiterated Rating$4.24$7.00Buy$0.0000.00% ROIVEEVVeeva Systems10/17/2025Reiterated Rating$292.71$340.00Buy$0.0000.00% ROIEVHEvolent Health9/30/2025Reiterated Rating$8.75$20.00Buy$0.0000.00% ROICYRXCryoPort9/18/2025Boost Price Target$8.87$15.00Buy$0.0000.00% ROIEVHEvolent Health9/9/2025Reiterated Rating$9.66$20.00Buy$0.0000.00% ROIHCATHealth Catalyst9/5/2025Reiterated Rating$3.30Neutral$0.0000.00% ROIVEEVVeeva Systems8/28/2025Boost Price Target$276.66$340.00Buy$0.0000.00% ROISLPSimulations Plus7/7/2025Lower Price Target$16.83$25.00Buy$00.0000.00% ROICYRXCryoPort7/7/2025Lower Price Target$7.29$10.00Buy$00.0000.00% ROIDOCSDoximity6/2/2025Upgrade$52.22$80.00Buy$00.0000.00% ROIPGNYProgyny3/31/2025Upgrade$22.51$28.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
